Published in Infection on August 01, 2004
Lovastatin: Immunomodulatory Value Evaluation (LIVE) | NCT00721305
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108. AIDS (2006) 0.90
Is statin therapy safe in patients with HIV/hepatitis C coinfection? Proc (Bayl Univ Med Cent) (2010) 0.82
Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. HIV AIDS (Auckl) (2014) 0.80
Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient. NDT Plus (2008) 0.76
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut (2007) 1.75
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann Neurol (1998) 1.60
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
Hepatotoxicity in patients prescribed efavirenz or nevirapine. Eur J Med Res (2008) 1.26
Multicenter quality assessment of PCR methods for detection of enteroviruses. J Clin Microbiol (1999) 1.23
[Not Available]. Medizinhist J (1986) 1.22
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun (1997) 1.09
Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system. J Med Virol (2001) 1.09
Gluten, a lectin with oligomannosyl specificity and the causative agent of gluten-sensitive enteropathy. Biochem Biophys Res Commun (1982) 1.00
Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients. Lancet (1996) 0.99
High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy. J Chromatogr B Biomed Sci Appl (2001) 0.98
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients. Eur J Med Res (2002) 0.97
Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology (1988) 0.96
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment. Eur J Med Res (2003) 0.94
Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol (1995) 0.94
Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis (2005) 0.93
Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo. J Infect Dis (1996) 0.92
Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups. J Clin Microbiol (1997) 0.91
Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS. Antimicrob Agents Chemother (1996) 0.91
Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed (2006) 0.88
[Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy]. Strahlenther Onkol (1987) 0.87
Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin. Eur J Med Res (2002) 0.87
Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection (1998) 0.86
Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections. J Clin Virol (1998) 0.86
The lectin properties of gluten as the basis of the pathomechanism of gluten-sensitive enteropathy. Klin Wochenschr (1983) 0.85
Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique. Mycoses (1999) 0.85
Orf followed by erythema multiforme. J Eur Acad Dermatol Venereol (2006) 0.84
A sebaceous tumor in a patient with acquired immunodeficiency syndrome. Eur J Med Res (2002) 0.83
Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology (2001) 0.82
[ACTH determination in the plasma from the cranial bulb of the jugular vein]. Klin Wochenschr (1966) 0.82
Follow-up of treated adult celiac disease: clinical and morphological studies. Hepatogastroenterology (1982) 0.81
Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir. Eur J Med Res (2000) 0.81
Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Hematol (2003) 0.81
Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole. J Clin Pharm Ther (1998) 0.81
High performance liquid chromatographic method for the determination of HIV-1 protease inhibitor tipranavir in plasma of patients during highly active antiretroviral therapy. Eur J Med Res (2008) 0.80
Replicative intermediates in bacteriophage M13 single stranded DNA synthesis. Hoppe Seylers Z Physiol Chem (1974) 0.80
Therapeutic drug monitoring of indinavir in HIV-infected patients undergoing HAART. Infection (2002) 0.79
Frequent detection of Mycoplasma pneumoniae in Bell's palsy. Eur Arch Otorhinolaryngol (2003) 0.79
Evaluation of an efavirenz-containing regimen: an open-label, multicenter study. HIV Clin Trials (2001) 0.79
Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infection. Infection (1997) 0.79
Gene transfer to human cells: transducing phage lambda plac gene expression in GMI-gangliosidosis fibroblasts. Proc Natl Acad Sci U S A (1975) 0.79
The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. Eur J Med Res (2010) 0.79
Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis. Eur J Med Res (2000) 0.79
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Ann Hematol (1999) 0.79
Influence of mexiletine on caffeine elimination. Pharmacol Ther (1987) 0.79
Replication of bacteriophage M13. Detachment of the parental DNA from the host membrane and transfer to progeny phages. Eur J Biochem (1971) 0.78
Toxic shock syndrome in AIDS. Int J Dermatol (1997) 0.78
Variability of bacterial gene-directed enzyme production in human genetically deficient cells. Hum Genet (1979) 0.78
High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy. J Chromatogr B Biomed Sci Appl (1999) 0.78
Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy. Neurology (1996) 0.77
[Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz]. Hautarzt (2005) 0.77
HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase beta 2-microglobulin levels in vitro. AIDS Res Hum Retroviruses (1994) 0.77
Subacute sclerosing panencephalitis in two brothers. Neuropediatrics (2003) 0.77
A 35-year-old bricklayer with hemimyoclonic jerks. Lancet (1998) 0.77
Efavirenz-therapy in HIV-patients with underlying liver disease: importance of continuous TDM of EFV. Eur J Med Res (2007) 0.76
Fulminant course in a case of diffuse myelinoclastic encephalitis-- a case report. Neuropediatrics (2001) 0.76
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS]. Dtsch Med Wochenschr (1995) 0.75
Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol (2005) 0.75
Abdominal T-cell non-Hodgkin's lymphoma of the gamma/delta type in a patient with selective immunoglobulin A deficiency. Am J Surg Pathol (1998) 0.75
Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues. Int J Cancer (1998) 0.75
Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. Eur J Med Res (2003) 0.75
[120 years of gastroenterological endoscopy--who was the first?]. Leber Magen Darm (1987) 0.75
[Immunogenetic findings in Crohn disease, ulcerative colitis and gluten sensitive enteropathy]. Z Gastroenterol (1984) 0.75
Gas chromatographic determination of trimethoprim in plasma during high-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis carinii pneumonia. J Chromatogr (1990) 0.75
[Bioterrorism and the lungs]. Dtsch Med Wochenschr (2004) 0.75
Evaluation of a pan-reactive hantavirus enzyme immunoassay and of a hantavirus immunoblot for the diagnosis of nephropathia epidemica. J Clin Virol (2001) 0.75
[MR tomographic volumetry of the subarachnoid space in HIV-associated brain atrophy]. Rofo (1992) 0.75
Liquid chromatographic method for the determination of uridine in human serum. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.75
Factors influencing the caffeine test for cytochrome P 448-dependent liver function. Arch Toxicol (1987) 0.75
[Do networks improve physician-patient relations?]. Dtsch Med Wochenschr (1999) 0.75
A case of pneumonia caused by Legionella pneumophila serogroup 8 in West Germany. Etiological diagnosis by immunofluorescence, enzyme immunoassay, and immunoblot. Klin Wochenschr (1987) 0.75
Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology. Z Gastroenterol (1993) 0.75
[One point determination of oral caffeine clearance in patients with liver diseases]. Z Gastroenterol (1988) 0.75
[An improved fluorimetric cortisol determination in serum: diagnostic significance and therapeutic conclusions in AGC insufficiency]. Klin Wochenschr (1970) 0.75
[Diagnosis of pheochromocytoma]. Lebensversicher Med (1987) 0.75